A Single-arm, Multicenter, Open-labeled Clinical Study of UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
Latest Information Update: 29 Apr 2025
At a glance
- Drugs Depoxythilone (Primary)
- Indications Advanced breast cancer; Brain metastases; HER2 negative breast cancer
- Focus Therapeutic Use
Most Recent Events
- 12 Sep 2022 New trial record